| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |